Introduction

Timothy Syndrome (TS) is a genetic disorder that is caused by an autosomal dominant inheritance pattern, which means that one allele from a parent needs to be mutated for their children to be carriers of this disease. The gene that is mutated is the CACNA1C gene, and this leads to a calcium channel defect, therefore leading to longer QT intervals, which correspond to the heart being affected. As well as this, patients present with learning difficulties and are mentally challenged in some cases, alongside presenting with webbed fingers or toes. This is referred to as syndactyly.¹ It is a rare genetic disorder, as despite this disease being autosomal dominant in nature, the mutation is very rare and clinical studies typically review individual studies (i.e., case reports) or studies comprise very few patients. This is due to TS having a very low prevalence amongst the general population.² Due to this genetic disorder being rare, many people with the disorder may receive inadequate or untimely treatment, as this condition is not widely publicised. It is therefore important to understand this condition, including the causes, symptoms, and treatment strategies. This article will provide an overview of TS by exploring these factors as well as the overall prognosis for those affected and future research and prevention strategies. 

Definition of timothy syndrome

Timothy syndrome is genetic and is caused by mutations in which a glycine unit is substituted for an arginine unit within the CACNA1C gene, which codes for a calcium channel subunit known as Cav1.2. This mutation can take place in two coding regions of the gene, exon 8 or 8a and this leads to TS1 and TS2, which will be explored in the later sections of this article.³ As aforementioned, this condition is autosomal dominant, thus only one parent needs to carry the faulty allele, which leads to TS presentation in the child.¹ Timothy syndrome affects calcium channels by affecting the voltage-dependent and calcium-dependent mechanisms within these channels. This leads to the alum channels being dysfunctional and inactive, which causes issues with the heart, hence longer QT times as mentioned previously. The mutation leads to the

subunit within calcium channels that form pores being affected, and this leads to a variety of issues with both the heart and development.⁴

Types of timothy syndrome

As mentioned previously, there are two types of TS referred to as TS1 and TS2, respectively. In the TS1 variant of this condition, the mutation occurs on exon 8A, whereas the mutation occurs on exon 8 for TS2. TS1 is typically referred to as the classical TS form, and this typically leads to less serious forms of autism than TS2, which is the variant with more severe side effects. As exon 8 is more prevalent in the brain than exon 8A TS2, this is the reason for a more serious impact on brain function in TS2 instances. Exon 8 is also more prevalent in the heart than exon 8A, therefore leading to more serious consequences in this region of the body.⁵ TS2 patients, although typically having hip extra symptoms regarding the heart, brain development and also hip dysplasia, TS1 patients tend to exclusively have syndactyly.¹

Symptoms and clinical features

This condition leads to a variety of different symptoms, some of which are unique to TS cases. Firstly, TS affects the heart greatly. Timothy syndrome leads to ventricular arrhythmias, which are when a heartbeat that is faster than usual originates from the ventricles. This is a major cause of concern, as if the heart beats at a rate that is much faster than usual, cardiac arrest is likely. As aforementioned, long QT syndrome is also a risk. This is when the heart rhythm is suddenly disrupted and leads to longer QT intervals when the heartbeat is measured using an electrocardiogram.⁶ Neurological and developmental issues are also commonplace amongst TS patients. Autism spectrum disorder (ASD) leads to those with TS struggling with human interaction and learning, and this generally presents itself early in life for those with the condition.⁷ Other intellectual disabilities which affect learning are also more prevalent in TS patients when compared to the general population.⁸ There are a few physical abnormalities that are indicative of this syndrome, including syndactyly (webbed fingers and toes), alongside tissues being short around joints, thus leading to a deformity and impaired motion. This is known as joint contracture.⁹ The immune system is also weaker in TS instances, and many patients present with pneumonia; this is thought to be due to the calcium channel that is affected, increasing immunity within humans.¹⁰

Causes and genetic basis

Timothy syndrome is caused by genetic factors and mechanisms. As mentioned previously, a point mutation in the CACNA1C gene leads to defects in the Cav1.2 calcium channel. There are two different mutations in which a glycine base is replaced by another base. Glycine 402 can be replaced by serine, and glycine 406 can be replaced by an arginine base, the latter being more present during TS1, and the first mutation mentioned typically being implicated in TS2 presentation.³ The Cav1.2 calcium channel regulates the calcium action potential, and it is responsible for the excitation-contraction coupling (ECC) processes that regulate heartbeat. The voltage-dependent and calcium-dependent mechanisms governing these processes are compromised due to the gene mutation, and this leads to higher Ca2+ levels in the channel, therefore leading to effects on the heart and cardiac system. These channels are also present in the brain and other regions of the body, and different phenotypes are present depending on which exon is affected.¹¹ Timothy syndrome is autosomal dominant in nature, and the mutations are referred to as de novo mutations, meaning that these mutations did not occur in the parents of those affected. This is possible due to the autosomal dominant nature of TS, and the mutations are sporadic.¹²

Diagnosis and detection

There are strategies to detect and diagnose TS in those affected. Firstly, genetic testing can be utilised in which the coding region of the CACNA1C gene is analysed to assess whether the TS mutations have occurred. It is important to look at exons 8 and 8A as these regions are affected by the mutation.¹³ Electrocardiograms (ECGs) can also test for TS as QT intervals are longer in TS patients, and this is a very prevalent indicator of this disease. Arrhythmias and other irregular heartbeat conditions can also be tested by utilising an ECG.¹⁴ Other ways of testing include neurological assessments to test for developmental and neurological disorders such as ASD. As well as this, physical assessments are useful as they test for syndactyly, which is common in TS1 instances.¹⁵

Treatment and management

Managing TS is possible due to a few different strategies. Different medications, such as calcium and sodium channel blockers alongside beta-receptor blockers, are used to treat

issues regarding the heart and its rhythm, although these drugs will not necessarily work in all TS instances.¹⁶ In severe TS instances, a pacemaker can be implanted to control the ECC processes that are compromised. There are also implantable defibrillators that perform a similar function, although these strategies are used when other strategies typically fail.¹⁷ Speech and physical therapy is used for those with developmental disorders and physical abnormalities such as syndactyly.³ Monitoring symptoms such as cardiac defects over time is important, and continued care is crucial to ensure optimum patient outcomes.¹⁸

Prognosis and life expectancy

Timothy syndrome affects the quality of life and the life expectancy of those affected. Patients with TS have a very low life expectancy (less than 3 years) due to life-threatening complications such as arrhythmias and cardiac arrests that can lead to death.¹⁹ Treatments are limited as medications are not always effective, and in addition to this, surgical procedures and implants may be dangerous to infants with TS who present with severe cardiac issues.²⁰ Diagnosing those affected early with young genetic techniques avoids serious cardiac issues and allows treatment to be administered as quickly as possible to maximise survival rates.¹⁸

Research and future directions

There is research regarding TS treatments that will hopefully lead to better patient outcomes in the future. Gene therapies are being increasingly used and researched, such as antisense oligonucleotides that prevent the TS mutations leading to a different protein structure in the calcium channel CAv1.2. These therapies are improving rapidly.²¹ Precision medicine in the form of stem cell and other treatments aims to prevent cardiac issues from occurring. It is important to carry out research on different treatments and screening techniques to lower TS prevalence and improve outcomes for those affected using new technology and advancements in understanding.²²

Summary

In summary, Timothy syndrome is caused by a genetic mutation in the CACNA1C gene and leads to devastating patient outcomes due to the risk of sudden death as well as a lower quality of life for survivors. There are treatments available, however, and the quality of treatments and the variety of what is available are improving over time. Detecting cases early, either by screening or closely monitoring those with suspected symptoms is crucial in allowing early treatment to be administered.

Increased awareness and research are paramount in improving the outcomes for those affected, and support will mean that those with this condition can try to live a relatively normal life if possible. Hopefully, with further developments in treatment and management, this disease will not have a devastating prognosis as it does in its current state.